NONSTEROIDAL ANTIINFLAMMATORY DRUGS - BENEFIT TO RISK RATIO - HEALTH ECONOMICS IMPACT

被引：0

作者：

MAYNARD, A ^{[1
]}

机构：

[1] UNIV YORK,DEPT HLTH ECON,YORK YO1 5DD,N YORKSHIRE,ENGLAND

来源：

BRITISH JOURNAL OF RHEUMATOLOGY | 1992年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：253 / 253

页数：1

共 50 条

[1] NONSTEROIDAL ANTIINFLAMMATORY DRUGS - BENEFIT TO RISK RATIO - GASTROINTESTINAL EFFECTS
HAWKEY, CJ
[J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 251 - 251
[2] NONSTEROIDAL ANTIINFLAMMATORY DRUGS - BENEFIT TO RISK RATIO - TRANSCUTANEOUS NSAID THERAPY
GRAHAME, R
[J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 252 - 252
[3] NONSTEROIDAL ANTIINFLAMMATORY DRUGS - BENEFIT TO RISK RATIO - EPIDEMIOLOGY OF NSAID EFFECTS AND SIDE-EFFECTS
HUSBY, G
KVIEN, TK
[J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 250 - 250
[4] CHIRAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS - RISK-BENEFIT CONSIDERATIONS
LAPICQUE, F
DUBOIS, N
NETTER, P
[J]. REVUE DU RHUMATISME, 1993, 60 (11): : 780 - 784
[5] NONSTEROIDAL ANTIINFLAMMATORY DRUGS - BENEFIT RISK-EVALUATION IN RHEUMATIC DISEASES
FENNER, H
[J]. JOURNAL OF RHEUMATOLOGY, 1992, 19 : 98 - 99
[6] Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma
Epplein, Meira
Nomura, Abraham M. Y.
Wilkens, Lynne R.
Henderson, Brian E.
Kolonel, Laurence N.
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (04) : 507 - 514
[7] NONSTEROIDAL ANTIINFLAMMATORY DRUGS
CARDARIO, B
MCKINNON, AA
[J]. CANADIAN FAMILY PHYSICIAN, 1991, 37 : 171 - 180
[8] NONSTEROIDAL ANTIINFLAMMATORY DRUGS
FENN, C
SHIELD, M
[J]. IRISH MEDICAL JOURNAL, 1990, 83 (01) : 40 - 41
[9] NONSTEROIDAL ANTIINFLAMMATORY DRUGS
ABRAMSON, SB
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 624 : 40 - 44
[10] NONSTEROIDAL ANTIINFLAMMATORY DRUGS
JOHNSON, AG
QUINN, DI
DAY, RO
[J]. MEDICAL JOURNAL OF AUSTRALIA, 1995, 163 (03) : 155 - 158

← 1 2 3 4 5 →